Ezharima launched in Japan as first dual EZH1 and EZH2 inhibitor therapy for leukemiaLymphoma
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
The current ruling will assure the safety of the use of Ranitidine for Indian patients
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
More women centric initiatives being the need of the hour for holistic development
Subscribe To Our Newsletter & Stay Updated